Waters UPLC and Mass Spectrometry Systems Approved for In-Vitro Diagnostic use in Brazil
Clinical laboratories now have access to enhanced levels of selectivity, sensitivity, and versatility from Waters’ newest UPLC-MS/MS technologies MILFORD, Mass.–(BUSINESS WIRE)–Jun. 8, 2017– Waters Corporation (NYSE: WAT) today announced that Brazil’sNational Health Surveillance Agency (ANVISA) has approved the Waters® ACQUITY® UPLC®, ACQUITY UPLC® I-Class System, and three mass spectrometers, the Xevo® TQD, Xevo TQ-S micro,... Read more